Lipidomics studies on macrophages - RAW 264.7 cells treated with Kdo2-Lipid A and compactin

Introduction | Browse | Search | Download
Mouse-over the above links for more information

Treatment details

LM ID Analyte Treatment Time(hrs) Sample ID Value Units
- tetranor 12(R) HETE cPLA2i 1.0 BCD110605C16 0.445 pmol/ml of medium
- tetranor 12(R) HETE cPLA2i 1.0 BCD110605C18 0.623 pmol/ml of medium
- tetranor 12(R) HETE cPLA2i 1.0 BCD110605C17 0.487 pmol/ml of medium
- tetranor 12(R) HETE cPLA2i 4.0 BCD110605C34 0.513 pmol/ml of medium
- tetranor 12(R) HETE cPLA2i 4.0 BCD110605C36 0.472 pmol/ml of medium
- tetranor 12(R) HETE cPLA2i 4.0 BCD110605C35 0.724 pmol/ml of medium
- tetranor 12(R) HETE cPLA2i 20.0 BCD110605C53 1.07 pmol/ml of medium
- tetranor 12(R) HETE cPLA2i 20.0 BCD110605C54 0.811 pmol/ml of medium
- tetranor 12(R) HETE cPLA2i 20.0 BCD110605C52 0.751 pmol/ml of medium
- tetranor 12(R) HETE PLDi 1.0 BCD110605C10 0.483 pmol/ml of medium
- tetranor 12(R) HETE PLDi 1.0 BCD110605C12 0.631 pmol/ml of medium
- tetranor 12(R) HETE PLDi 1.0 BCD110605C11 0.509 pmol/ml of medium
- tetranor 12(R) HETE PLDi 4.0 BCD110605C30 0.57 pmol/ml of medium
- tetranor 12(R) HETE PLDi 4.0 BCD110605C29 0.469 pmol/ml of medium
- tetranor 12(R) HETE PLDi 4.0 BCD110605C28 0.796 pmol/ml of medium
- tetranor 12(R) HETE PLDi 20.0 BCD110605C48 0.546 pmol/ml of medium
- tetranor 12(R) HETE PLDi 20.0 BCD110605C47 0.882 pmol/ml of medium
- tetranor 12(R) HETE PLDi 20.0 BCD110605C46 0.638 pmol/ml of medium
- tetranor 12(R) HETE KDO+cPLA2i 1.0 BCD110605C19 0.559 pmol/ml of medium
- tetranor 12(R) HETE KDO+cPLA2i 1.0 BCD110605C21 0.378 pmol/ml of medium
- tetranor 12(R) HETE KDO+cPLA2i 1.0 BCD110605C20 0.449 pmol/ml of medium
- tetranor 12(R) HETE KDO+cPLA2i 4.0 BCD110605C39 0.27 pmol/ml of medium
- tetranor 12(R) HETE KDO+cPLA2i 4.0 BCD110605C37 0.314 pmol/ml of medium
- tetranor 12(R) HETE KDO+cPLA2i 4.0 BCD110605C38 0.397 pmol/ml of medium
- tetranor 12(R) HETE KDO+cPLA2i 20.0 BCD110605C55 0.777 pmol/ml of medium
- tetranor 12(R) HETE KDO+cPLA2i 20.0 BCD110605C57 0.672 pmol/ml of medium
- tetranor 12(R) HETE KDO+cPLA2i 20.0 BCD110605C56 0.937 pmol/ml of medium
- tetranor 12(R) HETE KDO+PLDi 1.0 BCD110605C15 0.518 pmol/ml of medium
- tetranor 12(R) HETE KDO+PLDi 1.0 BCD110605C14 0.431 pmol/ml of medium
- tetranor 12(R) HETE KDO+PLDi 1.0 BCD110605C13 0.479 pmol/ml of medium
- tetranor 12(R) HETE KDO+PLDi 4.0 BCD110605C32 0.454 pmol/ml of medium
- tetranor 12(R) HETE KDO+PLDi 4.0 BCD110605C31 0.358 pmol/ml of medium
- tetranor 12(R) HETE KDO+PLDi 4.0 BCD110605C33 0.545 pmol/ml of medium
- tetranor 12(R) HETE KDO+PLDi 20.0 BCD110605C49 0.779 pmol/ml of medium
- tetranor 12(R) HETE KDO+PLDi 20.0 BCD110605C51 0.843 pmol/ml of medium
- tetranor 12(R) HETE KDO+PLDi 20.0 BCD110605C50 1.03 pmol/ml of medium
- tetranor 12(R) HETE KDO + ATP 1.0 BCD110605C07 0.35 pmol/ml of medium
- tetranor 12(R) HETE KDO + ATP 1.0 BCD110605C09 0.34 pmol/ml of medium
- tetranor 12(R) HETE KDO + ATP 1.0 BCD110605C08 0.425 pmol/ml of medium
- tetranor 12(R) HETE KDO + ATP 4.0 BCD110605C25 0.456 pmol/ml of medium
- tetranor 12(R) HETE KDO + ATP 4.0 BCD110605C26 0.472 pmol/ml of medium
- tetranor 12(R) HETE KDO + ATP 4.0 BCD110605C27 0.681 pmol/ml of medium
- tetranor 12(R) HETE KDO + ATP 20.0 BCD110605C45 0.504 pmol/ml of medium
- tetranor 12(R) HETE KDO + ATP 20.0 BCD110605C43 0.931 pmol/ml of medium
- tetranor 12(R) HETE KDO + ATP 20.0 BCD110605C44 0.553 pmol/ml of medium
- tetranor 12(R) HETE C 0.0 BCD110605C02 0.596 pmol/ml of medium
- tetranor 12(R) HETE C 0.0 BCD110605C01 0.756 pmol/ml of medium
- tetranor 12(R) HETE C 0.0 BCD110605C03 0.557 pmol/ml of medium
- tetranor 12(R) HETE C 1.0 BCD110605C06 0.485 pmol/ml of medium
- tetranor 12(R) HETE C 1.0 BCD110605C05 0.464 pmol/ml of medium